Evidence map›Paper›PMID 7964462›Full record

ArticleThe Journal of experimental medicine1994

Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.

E L Prak, M Trounstine, D Huszar, M Weigert

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mechanisms of central tolerance for B cells.Nature reviews. Immunology · 2017
    Review
  6. Article
  7. SLAP deficiency decreases dsDNA autoantibody production.Clinical immunology (Orlando, Fla.) · 2014
    Article
  8. Article
  9. Article
  10. Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  11. Article
  12. Article
  13. Alternative mechanisms of receptor editing in autoreactive B cells.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  14. B cell receptor editing in tolerance and autoimmunity.Annals of the New York Academy of Sciences · 2011
    Review
  15. Regulation of the B cell receptor repertoire and self-reactivity by BAFF.Journal of immunology (Baltimore, Md. : 1950) · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

E L PrakDepartment of Molecular Biology, Princeton University, New Jersey 08544.
M Trounstine
D Huszar
M Weigert
Princeton University · US

Funding

THE GENETIC CONTROL OF ANTIBODY DIVERSITY AND EXPRESSIONR01GM020964 · NIGMS · UNIVERSITY OF CHICAGO · PI WEIGERT, MARTIN G · 1985 to 2011
$5.7M
New strategies for expeditious oligosaccharide synthesisR15GM077170 · NIGMS · UNIVERSITY OF MISSOURI-ST. LOUIS · PI DEMCHENKO, ALEXEI V · 2006 to 2011
$748k
GENETIC CONTROL OF THE ANTIBODY STRUCTURER37GM020964 · NIGMS · PRINCETON UNIVERSITY · PI WEIGERT, MARTIN G · 1987 to 1996
–
ARRA NIH HHS 1RA43A132268-01NIGMS NIH HHS 5-T32GM077170NIGMS NIH HHS GM-20964
6 · The paper itself

Abstract

The genetic organization of the kappa and lambda light chain loci permits multiple, successive rearrangement attempts at each allele. Multiple rearrangements allow autoreactive B cells to escape clonal deletion by editing their surface receptors. Editing may also facilitate efficient B cell production by salvaging cells with nonproductive light chain (L chain) rearrangements. To study receptor editing of kappa L chains, we have characterized B cells from mice hemizygous for the targeted inactivation of kappa (JCkD/wt) which have an anti-DNA heavy chain transgene, 3H9. Hybridomas from JCkD/wt mice exhibited an increased frequency of rearrangements to downstream Jk segments (such as Jk5) compared with most surveys from normal mice, consistent with receptor editing by sequential kappa locus rearrangements in JCkD/wt. We observed an even higher frequency of rearrangements to Jk5 in 3H9 JCkD/wt animals compared with nontransgenic JCkD/wt, consistent with editing of autoreactive kappa in 3H9 JCkD/wt. We also recovered a large number of 3H9 JCkD/wt lines with Vk12/13-Jk5 rearrangements and could demonstrate by PCR and Southern analysis that up to three quarters of these lines underwent multiple kappa rearrangements. To investigate editing at the lambda locus, we used homozygous kappa-deficient animals (JCkD/JCkD and 3H9 JCkD/JCkD). The frequencies of V lambda 1 and V lambda 2 rearrangements among splenic hybridomas in 3H9 JCkD/JCkD were reduced by 75% whereas V lambda X was increased 5-10-fold, compared with nontransgenic JCkD/JCkD animals. This indicates that V lambda 1 and V lambda 2 are negatively regulated in 3H9 JCkD/JCkD, consistent with earlier studies that showed that the 3H9 heavy chain, in combination with lambda 1 binds DNA. As successive lambda rearrangements to V lambda X do not inactivate V lambda 1, the consequence of lambda editing in 3H9 JCkD/JCkD would be failed allelic exclusion at lambda. However, analysis of 18 3H9 JCkD/JCkD hybridomas with V lambda 1 and V lambda X DNA rearrangements revealed that most of these lines do not have productive lambda 1 rearrangements. In sum, both kappa and lambda loci undergo editing to recover from nonproductive rearrangement, but only kappa locus editing appears to play a substantial role in rescuing autoreactive B cells from deletion.

Indexed as

Gene RearrangementImmune ToleranceAnimalsBase SequenceB-LymphocytesHybridomasImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsMiceMice, TransgenicMolecular Sequence DataImmunoglobulin kappa-ChainsImmunoglobulin lambda-Chains

Identifiers

PMID7964462
PMCPMC2191736
OpenAlexW2005098855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.